Internal Medicine, Gastroenterology · Fort Collins, CO
NPI
1154597979
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3702 S Timberline Rd, Bldg A
Fort Collins, CO, 80525
Phone (970) 307-9773
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
2,416 services
Medicare patients, 2024
525
Average age 72
Drug cost, 2024
$169K
1,857 prescriptions
Company payments, 2025
$242
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Hampton was code 88305 (surgical pathology examination), 579 times for 299 patients. In total Daniel Hampton billed 2,416 services in 53 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 579 | 299 | $25.31 | $15K |
| 45385 Colonoscopy - Lesion Removal | Facility | 227 | 226 | $206.13 | $47K |
| 45380 Lower GI Endoscopy - Other | Facility | 141 | 141 | $68.06 | $9,596 |
| 99213 Office E&M - Established | Office | 91 | 82 | $65.29 | $5,942 |
| 43239 Upper GI Endoscopy | Facility | 74 | 70 | $62.72 | $4,641 |
| 99203 Office E&M - New | Office | 43 | 43 | $70.22 | $3,019 |
| 99222 Hospital E&M - Initial | Facility | 40 | 40 | $95.57 | $3,823 |
| 43235 Upper GI Endoscopy | Facility | 38 | 36 | $75.50 | $2,869 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 32 | 32 | $174.63 | $5,588 |
| 99232 Hospital E&M - Subsequent | Facility | 26 | 23 | $58.88 | $1,531 |
| 43248 Upper GI Endoscopy | Facility | 22 | 21 | $107.86 | $2,373 |
| 43249 Upper GI Endoscopy | Facility | 20 | 17 | $95.99 | $1,920 |
| 88312 Surgical Pathology Examination | Office | 17 | 16 | $62.51 | $1,063 |
| 99214 Office E&M - Established | Office | 12 | 12 | $87.11 | $1,045 |
By year: 2022 $104K for 1,571 services; 2023 $114K for 1,582 services; 2024 $136K for 2,416 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 579 | 299 | $25.31 | $15K |
| 88312 Surgical Pathology Examination | 17 | 16 | $62.51 | $1,063 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Hampton prescribed most often to Medicare patients was Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 428 prescriptions and refills. In total Daniel Hampton wrote 1,857 Medicare prescriptions that cost $169K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 428 | 428 | 426 | $7,575 |
| Pantoprazole Sodium Generic | 327 | 646 | 83 | $3,245 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 315 | 315 | 311 | $7,194 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 298 | 298 | 297 | $4,803 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 124 | 124 | 123 | $1,834 |
| Omeprazole Generic | 52 | 101 | 16 | $655 |
| Budesonide Dr Budesonide | 43 | 70 | 12 | $3,694 |
| Colestipol Hcl Generic | 27 | 41 | Under 11 | $1,792 |
| Creon Lipase/Protease/Amylase | 25 | 31 | Under 11 | $70K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 22 | 22 | 21 | $1,546 |
| Linzess Linaclotide | 20 | 44 | Under 11 | $23K |
| Mesalamine Generic | 15 | 27 | Under 11 | $4,723 |
| Budesonide Ec Budesonide | 12 | 27 | Under 11 | $612 |
| Cholestyramine Light Cholestyramine | 11 | 21 | Under 11 | $868 |
Brand drugs: - claims; generic drugs: 1,341 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Hampton $242 ($242 in general payments such as food, travel and fees) from 5 companies. The largest payer was Gilead Sciences, Inc. with $169.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.